UFBP1 could enhance the sensitivity of the gastric cancer cells to cisplatin by mediating the K48-linked polyubiquitin of the oxidative stress-response transcription factor Nrf2 and promoting its proteasome-mediated degradation. Here, DDRGK1 is linked to gastric cancer.